FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at treating a temporary deterioration of the gastrointestinal motor function caused by patient's postoperative intestinal obstruction. Administered is a therapeutically effective amount of a peptidyl ghrelin analogue.
EFFECT: method enables reducing toxicity and providing higher therapeutic effectiveness.
35 cl, 6 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR STIMULATION OF GASTROINTESTINAL TRACT LOCOMOTIVE FUNCTION | 2006 |
|
RU2420305C2 |
| GRELIN ANALOGS | 2003 |
|
RU2315059C2 |
| GHRELIN ANALOGUES | 2003 |
|
RU2373220C2 |
| GHRELIN ANALOGUES | 2006 |
|
RU2427587C2 |
| PHARMACEUTICAL COMPOSITION OF LIGANDS OF RECEPTORS OF SECRETAGOGUES OF GROWTH HORMONE | 2011 |
|
RU2523566C2 |
| RELEASING PEPTIDES OF GROWTH HORMONE | 2003 |
|
RU2323941C2 |
| METHOD FOR THERAPEUTIC PEPTIDES SYNTHESIS | 2012 |
|
RU2625793C2 |
| ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
| APPLICATION OF MELANOCORTIN FOR TREATING INSULIN SENSITIVITY | 2008 |
|
RU2453328C2 |
| METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCORTIN 4 RECEPTOR PATH | 2016 |
|
RU2785889C1 |
